Table 2 Demographic breakdown of patients enrolled in pilot clinical study.
From: Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer
Characteristic | Biopsies |
|---|---|
Number of Patients | |
Ultrasound (US) biopsy | 37 |
Mammoplasty biopsy | 6 |
Patient Demographics | |
Average Age (range) | 55 (25–79) |
Average BMI (range) | 30 (18–54.4) |
Pathology Breakdown | |
Malignant (US only) | 27 (73%) |
Benign (US only) | 10 (27%) |
Receptor Status (malignant only) | |
ER+,− | 22 (81%), 5 (19%) |
PR+,− | 19 (70%), 8 (30%) |
Her2+,− | 5 (19%), 22 (81%) |
TNBC | 4 (15%) |
Menopausal Status | |
Pre-menopause | 14 (37%) |
Peri-menopause | 1 (2%) |
Post-menopause | 23 (61%) |
Breast Density | |
Fatty | 4 (11%) |
Scattered Fibroglandular | 13 (35%) |
Heterogeneous Density | 15 (41%) |
Extremely Dense | 5 (13%) |
